CLOT STIFFNESS MEASURED BY SEER SONORHEOMETRY AS A MARKER OF POOR PROGNOSIS IN HOSPITALIZED COVID-19 PATIENTS
Francisco José López-Jaime, Sandra Martín-Téllez, Alberto Doblas-Márquez, Ignacio Márquez-Gómez, José María Reguera-Iglesias, Manuel Isidro Muñoz-Pérez, Ihosvany Fernández-Bello, View ORCID ProfileAdrián Montaño
doi: https://doi.org/10.1101/2021.07.13.21260256
Francisco José López-Jaime
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)
Sandra Martín-Téllez
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)
Alberto Doblas-Márquez
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)
Ignacio Márquez-Gómez
†Servicio de Enfermedades Infecciosas, Hospital Universitario Regional de Málaga, Málaga, Spain; (I.M.-G.); (J.M.R.-I)
José María Reguera-Iglesias
†Servicio de Enfermedades Infecciosas, Hospital Universitario Regional de Málaga, Málaga, Spain; (I.M.-G.); (J.M.R.-I)
Manuel Isidro Muñoz-Pérez
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)
Ihosvany Fernández-Bello
‡Biopharm, Novo Nordisk, Madrid, Spain; (I.F.-B)
Adrián Montaño
*Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain; (F.J.L.J.); (S.M.-T); (A.D.-M.); (M.I.M.-P.)

- Supplementary file 1[supplements/260256_file03.xlsx]
Posted July 16, 2021.
CLOT STIFFNESS MEASURED BY SEER SONORHEOMETRY AS A MARKER OF POOR PROGNOSIS IN HOSPITALIZED COVID-19 PATIENTS
Francisco José López-Jaime, Sandra Martín-Téllez, Alberto Doblas-Márquez, Ignacio Márquez-Gómez, José María Reguera-Iglesias, Manuel Isidro Muñoz-Pérez, Ihosvany Fernández-Bello, Adrián Montaño
medRxiv 2021.07.13.21260256; doi: https://doi.org/10.1101/2021.07.13.21260256
CLOT STIFFNESS MEASURED BY SEER SONORHEOMETRY AS A MARKER OF POOR PROGNOSIS IN HOSPITALIZED COVID-19 PATIENTS
Francisco José López-Jaime, Sandra Martín-Téllez, Alberto Doblas-Márquez, Ignacio Márquez-Gómez, José María Reguera-Iglesias, Manuel Isidro Muñoz-Pérez, Ihosvany Fernández-Bello, Adrián Montaño
medRxiv 2021.07.13.21260256; doi: https://doi.org/10.1101/2021.07.13.21260256
Subject Area
Subject Areas
- Addiction Medicine (280)
- Allergy and Immunology (580)
- Anesthesia (141)
- Cardiovascular Medicine (1962)
- Dermatology (187)
- Emergency Medicine (335)
- Epidemiology (11123)
- Gastroenterology (629)
- Genetic and Genomic Medicine (3196)
- Geriatric Medicine (310)
- Health Economics (567)
- Health Informatics (2049)
- Health Policy (864)
- Hematology (310)
- HIV/AIDS (685)
- Medical Education (318)
- Medical Ethics (92)
- Nephrology (337)
- Neurology (3004)
- Nursing (165)
- Nutrition (465)
- Oncology (1561)
- Ophthalmology (478)
- Orthopedics (186)
- Otolaryngology (266)
- Pain Medicine (202)
- Palliative Medicine (57)
- Pathology (403)
- Pediatrics (914)
- Primary Care Research (355)
- Public and Global Health (5613)
- Radiology and Imaging (1101)
- Respiratory Medicine (764)
- Rheumatology (341)
- Sports Medicine (289)
- Surgery (348)
- Toxicology (48)
- Transplantation (159)
- Urology (133)